CN103768150A - Traditional Chinese medicine effective part composition for treating cataract - Google Patents
Traditional Chinese medicine effective part composition for treating cataract Download PDFInfo
- Publication number
- CN103768150A CN103768150A CN201310568900.1A CN201310568900A CN103768150A CN 103768150 A CN103768150 A CN 103768150A CN 201310568900 A CN201310568900 A CN 201310568900A CN 103768150 A CN103768150 A CN 103768150A
- Authority
- CN
- China
- Prior art keywords
- part composition
- chinese medicinal
- medicinal effective
- treatment
- cataract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a traditional Chinese medicine effective part composition for treating cataract, which adopts such raw materials in parts by weight as fructus caryophylli, ferula asafetida, fraxinus chinensis, blumea balsamifera, senecio scandens and coriolus versicolor. The traditional Chinese medicine effective part composition provided by the invention has the effects of tonifying the liver and kidney, nourishing yin, improving eyesight, invigorating spleen, supplementing qi, promoting blood circulation to remove blood stasis, removing cataract and nourishing the stomach, is effective in treatment of cataract, has no side effects, and is high in safety.
Description
Technical field
The present invention relates to Chinese medicine composition field, be specifically related to one and be used for the treatment of cataractous Chinese medicinal effective-part composition.
Background technology
Cataract, is a kind of oculopathy affecting one's power of vision because crystalline lens is muddy, is more common in old people, is also a kind of common complication of diabetes.In addition, touching some harmful substance, injure the generation that congenital factor also can cause primary disease outward, is the one of the main reasons of current mankind's blinding.
Summary of the invention
The object of the present invention is to provide one for the preparation of the cataractous Chinese medicinal effective-part composition for the treatment of, this active component composition can be treated cataract, and is difficult for recurrence.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
At present, the traditional Chinese medical science thinks that cataract is caused by worn with age, the reason such as natural endowment is not enough, wound or violence, and its pathogenesis is mainly the hepatic and renal YIN deficiency and deficiency of spleen-QI and stomach-QI and the stasis of blood.
One is treated cataractous Chinese medicinal effective-part composition, by making according to the raw material of mass fraction meter as follows: Fructus Caryophylli 24, Resina Ferulae 22, Chinese ash 21, Herba Blumeae Balsamiferae 17, Herba Senecionis Scandentis 14 and Coriolous Dersicolor (Fr.) Quel 2.
The preparation method of Chinese medicinal effective-part composition of the present invention be by above-mentioned raw materials compositions according to proportioning combination drying, add 16 times of water gagings, boil with high heat, change slow fire boiling into 3 hours, waste, to obtain final product.
Compared with prior art, the present invention has following beneficial effect:
Find through experiment, the Chinese medicinal effective-part composition of making according to proportioning of the present invention has liver and kidney tonifying, YIN nourishing improving eyesight, invigorating the spleen and benefiting QI, blood circulation promoting and blood stasis dispelling, the effect of barrier nourishing the stomach of dispelling, and can be used for the treatment of cataract, after curing, is difficult for recurrence.
The specific embodiment
Further explain the present invention below in conjunction with embodiment, but embodiment does not limit in any form to the present invention.
embodiment 1
Fructus Caryophylli 24g, Resina Ferulae 22g, Chinese ash 21g, Herba Blumeae Balsamiferae 17g, Herba Senecionis Scandentis 14g and Coriolous Dersicolor (Fr.) Quel 2g, add 16 times of water gagings after being dried, and after boiling, then uses slow fire decocting 180min with intense fire, and gained decoction is for subsequent use.
embodiment 2
500 of clinical observation cataract patients.Patient is all diagnosed as cataract through clinical diagnosis.Take embodiment 1 gained decoction to patient, 2 times on the 1st, sooner or later bfore meals, continuous 15 days.
Take patient's statistical result of embodiment 1 gained decoction in table 1.Wherein effectively comprise recovery from illness and effectively, recovery from illness refers to through treatment, check with international standard visual acuity chart, vision improve 3 row or more than; Effectively refer to that, through treatment, vision improves 1 ~ 2 row.Invalid refer to through treatment, vision unchanged or decline.
Table 1
| Number of cases | Effective | Invalid | Obvious effective rate (%) |
| 500 | 487 | 13 | 97.4 |
Known by above-mentioned data, Chinese medicine of the present invention is made after decoction, can be in 15 days the treatment cataract of highly significant.
embodiment 3
The decoction administration ICR mice that uses embodiment 1 to make, body weight 20 ~ 25g, male and female half and half, successive administration 60d.
Through prerun, the decoction toxicity that embodiment 1 makes is very low, does not measure LD50, measures therefore mice is carried out to maximum dosage-feeding on the one.Maximum dosage-feeding is 400ml/d, observes none example and be poisoned to death after 60 days, and all healthy survival, proves that the decoction that compositions of the present invention is made can toxic side effect to human body thus.
Claims (4)
1. the cataractous Chinese medicinal effective-part composition for the treatment of, is characterized in that by making according to the raw material of mass fraction meter as follows: Fructus Caryophylli 24, Resina Ferulae 22, Chinese ash 21, Herba Blumeae Balsamiferae 17, Herba Senecionis Scandentis 14 and Coriolous Dersicolor (Fr.) Quel 2.
2. the cataractous Chinese medicinal effective-part composition for the treatment of according to claim 1, is characterized in that described Chinese medicinal effective-part composition makes decoction.
3. described in claim 1 or 2, treat the preparation method of cataractous Chinese medicinal effective-part composition, it is characterized in that each crude drug, according to proportioning combination drying, adding 16 times of water gagings, boil with high heat, change slow fire boiling into 3 hours, waste, to obtain final product.
4. the application of Chinese medicinal effective-part composition described in claim 1 or 2, is characterized in that described Chinese medicinal effective-part composition is for the preparation of the cataractous medicine for the treatment of.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310568900.1A CN103768150A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating cataract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310568900.1A CN103768150A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating cataract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103768150A true CN103768150A (en) | 2014-05-07 |
Family
ID=50561210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310568900.1A Pending CN103768150A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating cataract |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103768150A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10195591B2 (en) | 2017-04-24 | 2019-02-05 | Suzhou Toreto New Material Ltd. | Binder-free high strength, low steam-to-oil ratio ethylbenzene dehydrogenation catalyst |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH045237A (en) * | 1990-04-24 | 1992-01-09 | Nonogawa Shoji Kk | Superoxide eliminant |
| US20090004334A1 (en) * | 2007-06-29 | 2009-01-01 | Vijaya Nair | Dietary nutritional supplements for heal thcare |
| CN103341020A (en) * | 2013-07-29 | 2013-10-09 | 阚景平 | Traditional Chinese medicine preparation for treating radiation cataract and preparation method thereof |
-
2013
- 2013-11-15 CN CN201310568900.1A patent/CN103768150A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH045237A (en) * | 1990-04-24 | 1992-01-09 | Nonogawa Shoji Kk | Superoxide eliminant |
| US20090004334A1 (en) * | 2007-06-29 | 2009-01-01 | Vijaya Nair | Dietary nutritional supplements for heal thcare |
| CN103341020A (en) * | 2013-07-29 | 2013-10-09 | 阚景平 | Traditional Chinese medicine preparation for treating radiation cataract and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 吴名波: "中药防治糖性白内障的作用机制研究进展", 《眼科新进展》, vol. 28, no. 4, 30 April 2008 (2008-04-30), pages 316 - 317 * |
| 李仕兴: "秦艽花椒散治疗耕牛内障眼", 《中国兽医科技》, vol. 25, no. 5, 31 December 1995 (1995-12-31), pages 11 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10195591B2 (en) | 2017-04-24 | 2019-02-05 | Suzhou Toreto New Material Ltd. | Binder-free high strength, low steam-to-oil ratio ethylbenzene dehydrogenation catalyst |
| US10406508B2 (en) | 2017-04-24 | 2019-09-10 | Suzhou Toreto New Material Ltd. | Binder-free high strength, low steam-to-oil ratio ethylbenzene dehydrogenation catalyst |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463539B (en) | A kind of medicine for the treatment of eczema and its production and use | |
| CN102319288B (en) | Pure traditional Chinese medicine composition for treating poultry infectious bursal disease and preparation method thereof | |
| CN103768150A (en) | Traditional Chinese medicine effective part composition for treating cataract | |
| CN103550744B (en) | A kind of pure Chinese medicinal preparation for oral ulcer | |
| CN103861007B (en) | A kind of Chinese herbal compound preparation for the treatment of chicken diarrhea | |
| CN103585580B (en) | A kind of Chinese medicine preparation for recurrent oral ulceration | |
| CN102670863B (en) | Compound propolis composition for treating acariasis of domestic animal and preparation method thereof | |
| CN102961487B (en) | Compound combination made from pure traditional Chinese medicines and used for treating henpox and preparation method of combination | |
| CN101732425B (en) | Externally-applied medicine composite for psoriasis | |
| CN104474405A (en) | Traditional Chinese medicine composition for treating chloasma | |
| CN103432333B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism | |
| CN103768341A (en) | Traditional Chinese medicine effective part composition for treating primary glaucoma | |
| CN104771569B (en) | A kind of Chinese medicine composition for treating chronic lymphadenitis | |
| CN103432204B (en) | Traditional Chinese medicine effective part composition for treating schizophrenia and preparation method thereof | |
| CN102228661B (en) | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis | |
| CN105853556A (en) | Medicine for treating fungal, viral and bacterial skin disease and sexual skin disease | |
| CN103768194A (en) | Traditional Chinese medicine effective part composition for treating rheumatic heart disease | |
| CN103585534A (en) | Traditional Chinese medicine effective part composition for treating erythema multiforme | |
| CN105687385A (en) | Ointment for treating radiodermatitis and preparation | |
| CN103768312A (en) | Traditional Chinese medicine effective part composition for treating Meniere's disease | |
| CN105381177A (en) | External use traditional Chinese medicine for treating sweet stains | |
| CN104001031A (en) | Medicament for treating asthma | |
| CN103432397B (en) | Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans | |
| CN103550294B (en) | Traditional Chinese medicine effective part composition for treating urticaria | |
| CN104435979B (en) | A kind of medicine for treating rheumatic lumbocrural pain pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |